REG - Surgical Innovations - Exercise of Options, Issue of Equity and TVR

Surgical InnovationsAnnouncement

27/09/2019 15:45

RNS Number : 0145O
Surgical Innovations Group PLC
27 September 2019
 


 
27 September 2019
Surgical Innovations Group plc 
("SI Group" or "the Company")
 
Exercise of Options, Issue of Equity & Total Voting Rights
 
 
Exercise of Options
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that it has today issued and allotted a total of 4,750,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") following an exercise of options.
 
Application has been made to the London Stock Exchange for the 4,750,000 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective at 8.00 a.m. on 3 October 2019.
 
Total Voting Rights
Following Admission, the Company will have 795,316,177 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 795,316,177.
 
 
 
For further information please contact:
 



Surgical Innovations Group Plc


www.sigroupplc.com




Nigel Rogers, Non-Executive Chairman


Tel: 0113 230 7597




Charmaine Day, Company Secretary & GFC


















N+1 Singer  (Nominated Advisor and Broker)
Richard Lindley


Tel: 020 7496 3000
 




Rachel Hayes
 








Walbrook PR (Financial PR & Investor Relations)


Tel: 020 7933 8780 or si@walbrookpr.com




Paul McManus
Lianne Cawthorne


Mob: 07980 541 893
Mob: 07584 391 303
 








 
 
 
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRLLFVSARIDFIA